Cargando…
Harnessing microbial iron chelators to develop innovative therapeutic agents
BACKGROUND: Bacterial infections involving multidrug-resistant Gram-negative bacteria have become critically involved in the current antibiotic crisis. This, together with the bacterial evolution ability, prioritizes the discovery of new antibiotics. Research on microbial iron acquisition pathways a...
Autores principales: | Ribeiro, Marta, Sousa, Cátia A., Simões, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263657/ https://www.ncbi.nlm.nih.gov/pubmed/35777919 http://dx.doi.org/10.1016/j.jare.2021.10.010 |
Ejemplares similares
-
Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
por: Chhabra, Ravneet, et al.
Publicado: (2020) -
Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
por: Kwiatkowski, Janet L
Publicado: (2011) -
Therapeutic potential of induced iron depletion using iron chelators in Covid-19
por: Poonkuzhi Naseef, Punnoth, et al.
Publicado: (2022) -
Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013) -
Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach
por: Islam, Sufia, et al.
Publicado: (2022)